Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Escherichia coli

ABSTRACT: Characterization of blaCTX-M-27/F1:A2:B20 plasmids spreading among elderly Japanese

PROVIDER: PRJDB9189 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR205405_1.fastq.gz	Fastqsanger.gz
	DRR205406_1.fastq.gz	Fastqsanger.gz
	DRR205407_1.fastq.gz	Fastqsanger.gz
	DRR205408_1.fastq.gz	Fastqsanger.gz
	DRR205409_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 69

Similar Datasets

Project description:E. coli with blaCTX-M-15 and blaCTX-M-27 carrying plasmids

| PRJNA887343 | ENA

Overcoming resistance to anti-VEGF therapy via epigenetic regulation of BARD1 [methylation]

Project description:Genome wide DNA methylation profiling of anti-VEGF resistant SKOV3 tumor samples treated with B20 and/or Azacytidine. The Illumina Infinium 450k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 450,000 CpGs in SKOV3 tumors. Samples included 2 control IgG, 2 Azacytidine, 2 B20 and 2 B20+Azacytidine treated SKOV3ip1 tumors.

2025-06-17 | GSE247655 | GEO

ena-DATASET-DKFZ-IBIOS-01-08-2014-15:53:49:885-84 - samples

Project description:Whole genome bisulfite sequencing data for 6 ependymomas plus 3 fetal controls (f1, f2, f4) and 3 adult controls (a2, a3, a4). See Mack, Witt et al. Nature 506(7489):445-50, 2014 (PMID: 24553142).

| EGAD00001000966 | EGA

Project description:Shigella sonnei sequence harbouring blaCTX-M-27 Italy

| PRJNA1145288 | ENA

Salmonella enterica subsp. enterica strain:SEN101134

Project description:Sequencing of IncI1 plasmids carrying the blaCTX-M genes

| PRJNA287296 | ENA

The 40S ribosomal subunit recycling complex modulates mitochondrial dynamics and endoplasmic reticulum - mitochondria tethering at mitochondrial fission/fusion hotspots

Project description:Samples 939560 F1-8 are the 8 fractions for the samples A1-D3, as well as F3, G3, H1, and I1 (these 4 were included in both sets and can be used to help normalize between sets). Samples 939560 F1-8 are the 8 fractions for the samples E1-I3, as well as A2 (included in both sets to help with normalization/comparison between sets). 939560: sample TMT Label A1 126 A2 127N A3 127C B1 128N B2 128C B3 129N C1 129C C2 130N C3 130C D1 131N D2 131C D3 132N F3 132C G3 133N H1 133C I1 134N 939561: sample TMT Label E1 126 E2 127N E3 127C F1 128N F2 128C F3 129N G1 129C G2 130N G3 130C H1 131N H2 131C H3 132N I1 132C I2 133N I3 133C A2 134N A1-A3: W minus- MHC> Gal4 (Control) B1-B3: WT- MHC-Gal4> USP10 OE C1-C3: WT- MHC-Gal4> USP10 Sh RNAi D1-D3: WT- MHC-Gal4> USP10 RNAi KK E1-E3: WT- MHC-Gal4> FMR1 OE F1-F3: WT- MHC-Gal4> FMR1 RNAi G1-G3: WT- MHC-Gal4> FMR1 RNAi H1-H3: WT- MHC-Gal4> RIN OE I1-I3: WT- MHC-Gal4> RIN RNAi

2025-01-10 | MSV000096824 | MassIVE

Investigation of the transcriptional effects of Bevacizumab treatment in two epithelial ovarian cancer PDX models

Project description:PDXs were established from cancer cells contained in ascitic effusions from patients with high-grade serous ovarian cancer, never treated with Bevacizumab. Tumors were propagated in female NOD/SCID mice by intraperitoneal injection of tumor cells. Two PDX models, one B20-4.1.1-Resistant (PDOVCA 69, n=5 samples/group) and one B20-4.1.1-Sensitive (PDOVCA 62, n=4 samples/group), were used to evaluate the transcriptional effects of B20-4.1.1 treatment with respect to untreated controls by microarrays. The biological material coming from the ascites of the two PDX models was analyzed at sacrifice following anti-VEGF treatment or control (PBS) treatment.

2024-12-05 | E-MTAB-14679 | biostudies-arrayexpress

Escherichia coli

Project description:Complete sequence analysis of I1 plasmids harboring blaCTX-M genes

| PRJDB9839 | ENA

Project description:Interspecies transfer of a blaCTX-M-27 containing lncFII plasmid

| PRJNA802079 | ENA

Project description:B20

| PRJEB102799 | ENA